Crossmark

A modified risk score in one-year survival rate assessment of group 1 pulmonary arterial hypertension

Crossref DOI link: https://doi.org/10.1186/s12890-018-0712-7

Published Online: 2018-10-16

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xiong, Wei

Zhao, Yunfeng

Xu, Mei

Pudasaini, Bigyan

Guo, Xuejun

Liu, Jinming
Funding

Funding for this research was provided by:

The Program of Shanghai Natural Science Foundation (16ZR1429000)

The Program of Development Center for Medical Science and Technology, National Health and Family Planning Commission of the People’s Republic of China (ZX-01-C2016144)
License Information

Text and Data Mining valid from 2018-10-16
More Information

Article History

Received: 21 April 2018

Accepted: 21 August 2018

First Online: 16 October 2018

Ethics approval and consent to participate

: This protocol was approved by the institutional review board of Shanghai Pulmonary Hospital. Written informed consent was obtained from all patients.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.